In ₹ Crore except Per Share Latest Annual	RPGLIFE FY26	GUFICBIO FY26	GUJTHEM FY26	UNICHEMLAB FY26	Peer Average
Valuation — at last close
P/E	157.30×	66.21×	83.07×	◆ 13.61×	54.30× +190%
P/B	7.77×	6.39×	13.46×	◆ 1.27×	7.04× +10%
EV/EBITDA	30.24×	30.12×	53.33×	◆ 19.63×	34.36× -12%
Market Cap	₹4,703 Cr	₹4,249 Cr	₹3,874 Cr	₹3,441 Cr	₹3,855 Cr +22%
Growth
Revenue CAGR 3Y	—	—	—	17.91%	17.91%
Revenue CAGR 5Y	—	—	—	12.26%	12.26%
Revenue YoY (latest Q)	—	16.58%	◆ 22.07%	20.13%	19.59%
Net Income YoY (latest Q)	—	70.71%	22.12%	◆ 496.08%	196.30%
Profitability
EBITDA Margin	20.79%	16.03%	◆ 45.55%	8.36%	23.31% -11%
Net Income Margin	16.28%	6.80%	◆ 28.15%	11.48%	15.48% +5%
Return on Common Equity	◆ 20.28%	10.14%	17.41%	9.78%	12.44% +63%
Return on Capital Employed	◆ 21.46%	15.00%	17.76%	2.18%	11.65% +84%
Return on Assets	◆ 15.88%	5.11%	11.60%	6.92%	7.88% +102%
Credit & Quality
Total Debt/Equity	◆ 0.03×	0.58×	0.56×	0.17×	0.44× -93%
Interest Coverage	◆ 141.13×	3.29×	21.23×	1.87×	8.80× +1504%
Scale — latest FY
Revenue / Total Income	₹708 Cr	₹944 Cr	₹166 Cr	₹2,202 Cr	₹1,104 Cr -36%
Net Income	₹115 Cr	₹64.2 Cr	₹46.7 Cr	₹253 Cr	₹121 Cr -5%
Total Assets	₹793 Cr	₹1,342 Cr	₹503 Cr	₹3,737 Cr	₹1,861 Cr -57%
EPS	₹18.08	₹6.4	₹4.28	₹35.91	₹15.53 +16%
Book Value per Share	₹366.07	₹66.31	₹26.41	₹386	₹159.57 +129%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.